Drug Search Results
More Filters [+]

Radavirsen

Alternative Names: radavirsen, avi-7100, avi7100, avi 7100
Latest Update: 2017-12-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: IAV Inhibitor

Novel Mechanism: Yes

Modality: Nucleic Acid

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sarepta
Company Location: CAMBRIDGE MA 02142
Company CEO: Douglas S. Ingram
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Radavirsen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

13-I-0029

P1

Completed

Influenza, Human

2016-06-29

7100-us-101

P1

Terminated

Influenza, Human

2011-08-01

Recent News Events

Date

Type

Title